Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials (Q28748654)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 29 October 2010)

Language	Label	Description	Also known as
English	Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials	scientific article (publication date: 29 October 2010)

Statements

scholarly article

0 references

Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials (English)

0 references

attenuated vaccine

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

0 references

Christopher S Ambrose

object named as

Christopher S Ambrose

3

0 references

8

object named as

George Kemble

0 references

author name string

Raburn M Mallory

1

0 references

Elissa Malkin

2

0 references

Terramika Bellamy

4

0 references

Li Shi

5

0 references

Tingting Yi

6

0 references

Taff Jones

7

0 references

Filip Dubovsky

9

0 references

language of work or name

0 references

publication date

29 October 2010

0 references

0 references

5

0 references

10

0 references

e13755

0 references

copyright license

Creative Commons Attribution 4.0 International

29 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Update on influenza A (H1N1) 2009 monovalent vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Mass distribution of free, intranasally administered influenza vaccine in a public school system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Laboratory and clinical characteristics of attenuated strains of influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

3 June 2018

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Live attenuated versus inactivated influenza vaccine in infants and young children.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

School-based influenza immunization.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Immunogenicity and Reactogenicity of 1 versus 2 Doses of Trivalent Inactivated Influenza Vaccine in Vaccine‐Naive 5–8‐Year‐Old Children

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0013755

21 January 2018

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

27 November 2018

Biologic and immunologic characteristics of cold-adapted influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966412

27 November 2018

Test-based exact confidence intervals for the difference of two binomial proportions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21060780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring antibody responses to a live attenuated influenza vaccine in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21060780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21060780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of school-based influenza vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21060780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21060780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0013755

0 references

2010PLoSO...513755M

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28748654&oldid=2100355634"